Form 4: Vita Coco CEO Sells Shares Under 10b5-1 Plan

Vita Coco Company CEO Martin Roper sold 40,000 shares of common stock across two days in late September 2025, pursuant to a pre-arranged Rule 10b5-1 trading plan.

Summary

• Martin Roper, Chief Executive Officer and Director of Vita Coco Company, Inc. (COCO), reported sales of common stock on September 29 and September 30, 2025.
• A total of 40,000 shares were sold across these two days, with 20,000 shares sold on each day.
• On September 29, 2025, 5,000 shares were sold directly at a weighted average price of $40.451, and 15,000 shares were sold indirectly through three family trusts (Christopher G. Roper Exempt Family Trust, Peter S. Roper Exempt Family Trust, and Thomas L. Roper Exempt Family Trust) at weighted average prices ranging from $40.437 to $40.469.
• On September 30, 2025, another 5,000 shares were sold directly at a weighted average price of $42.92, and 15,000 shares were sold indirectly through the same three family trusts at weighted average prices ranging from $42.902 to $42.943.
• All sales were effected pursuant to a Rule 10b5-1 trading plan.
• Following these transactions, Martin Roper directly beneficially owns 308,897 shares of common stock.
• Indirect beneficial ownership includes 243,406 shares by the Christopher G. Roper Exempt Family Trust, 242,515 shares by the Peter S. Roper Exempt Family Trust, 243,531 shares by the Thomas L. Roper Exempt Family Trust, and 61,200 shares by a spouse.
• Roper also holds 1,099,460 non-qualified stock options with various exercise prices and vesting schedules, including 620,620 fully vested options.

Sentiment

Score: 5

Explanation: The sentiment is neutral. While insider selling can sometimes be perceived negatively, the execution of these sales under a Rule 10b5-1 trading plan indicates they were pre-scheduled and not based on new material non-public information. This mitigates any strong negative interpretation, suggesting a planned diversification or liquidity event rather than a lack of confidence in the company's future.

Positives

• The sales were conducted under a Rule 10b5-1 trading plan, indicating they were pre-scheduled and not based on new material non-public information, which can mitigate concerns about insider selling.

Negatives

• The transactions represent a reduction in the direct and indirect equity holdings of the Chief Executive Officer and Director, which some investors may interpret as a lack of confidence, despite the pre-arranged nature of the sales.

Future Outlook

This filing, a Form 4, reports insider transactions and does not contain forward-looking statements or guidance regarding the company's future performance or strategic outlook.

Industry Context

This Form 4 filing reports routine insider stock transactions and does not provide specific information related to broader industry trends or competitive landscape within the beverage sector. The sales are part of a pre-arranged plan, which is a common practice for executives to manage their equity holdings.

Stakeholder Impact

• Shareholders: May observe a reduction in the CEO's direct and indirect equity stake, which could lead to varied interpretations. However, the 10b5-1 plan suggests a pre-planned transaction rather than a reaction to recent events.

Key Dates

Recommendation

The sales by CEO Martin Roper were executed under a Rule 10b5-1 trading plan, indicating they were pre-scheduled and not based on new material non-public information. While insider selling can sometimes be viewed negatively, the planned nature mitigates concerns. The transactions represent a reduction in direct and indirect equity holdings but do not inherently suggest a change in the company's fundamental outlook, thus a 'hold' recommendation is appropriate for existing investors, pending further operational updates.

Keywords

Vita Coco, COCO, Martin Roper, Insider Trading, Form 4, Stock Sale, 10b5-1 Plan, CEO, Director, Beverage Industry